Moneycontrol
HomeNewsBusinessFY21 revenue may be impacted due to COVID-19: ICICI Bank
Trending Topics

FY21 revenue may be impacted due to COVID-19: ICICI Bank

As part of its capital raising plans for the current fiscal year, the second largest private sector lender earlier this month informed about the board's decision to raise up to Rs 15,000 crore in core capital through various routes.

July 18, 2020 / 21:14 IST
Story continues below Advertisement

ICICI Bank expects its revenues to be impacted in 2020-21 due to the COVID-19 crisis and said it will look to maintain adequate liquidity and focus on robust credit monitoring. The economic conditions remain challenging going forward due to the uncertainties posed by the global health crisis and the stand-still in the economic activity, ICICI Bank said in its annual report 2019-20.

The Indian economy would be impacted by this pandemic with contraction in industrial and services output across small and large businesses, said the private sector lender.

Story continues below Advertisement

"While systemic liquidity is abundant, the economic weakness caused by the pandemic and uncertainty regarding normalisation will impact banking sector loan growth, revenues, margins, asset quality and credit costs.

"In view of the COVID-19 pandemic, there will be an impact on revenues and an increase in rating downgrades in the portfolio and NPA formation at a systemic level and for the bank," ICICI Bank said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show